Shares of Acasti Pharma (NASDAQ:ACST) are jumping more than 25% higher today after a major investment firm initiated coverage. ACST stock has declined by more than 50% year to date (YTD), vastly ...
Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Acasti Pharma (ACST) one of those stocks right now? Let's take a closer look at ...
Today’s late-stage pharmaceutical companies remind me of the old oil wildcatters from the 1920s. They spend a ton of money hyping a study, as wildcatters would a prospect. Then investors wait ...
Acasti Pharma (NASDAQ:ACST) is a classic example of the extreme volatility of small-cap biotech stocks. It was only in late December that the shares were fetching $2.87, up from $1 a year earlier. But ...
Today, Oppenheimer initiated coverage on ACST stock with an “outperform” rating and a price target of $6. Even after today’s significant price increase, the price target still represents upside of ...
Today, Oppenheimer initiated coverage on ACST stock with an “outperform” rating and a price target of $6. Even after today’s significant price increase, the price target still represents upside of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results